Skip to main content
. 2018 Jan 9;8:202. doi: 10.1038/s41598-017-18466-9

Figure 2.

Figure 2

(a) Kaplan-Meier survival curve of localized RCC according to lymphovascular invasion (LVI). Recurrence-free survival rate of patients with LVI and without LVI were 64.7% and 91.3% (p < 0.001, log rank test). Patients without LVI were correlated with a higher recurrence-free survival rate (p < 0.001, log rank test). (b) Patients without RCI in pT1 and pT2 were correlated with cancer recurrence, respectively (p < 0.001, p = 0.026, log rank test).